
INNOVATIVE SOLUTIONS FOR INHALATION SAFETY In vitro specialists for immune responses in the lung Speak to the team DELIVERING IN VITRO SOLUTIONS In vitro services for inhalation testing In vitro alveolar macrophage assays Immune-competent in vitro human airways models ImmuONE delivers innovative respiratory in vitro cell culture products and services focusing on innate immune responses […]
Location: United Kingdom, England, Bedford
Total raised: $777.39K
Funding Rounds 1
Date | Series | Amount | Investors |
13.03.2025 | - | $777.39K | - |
Mentions in press and media 4
Date | Title | Description |
13.03.2025 | ImmuONE Raises £600K in Funding | ImmuONE, a Stevenage, UK-based biotech startup developing a 3D laboratory model that provides an alternative to animal testing, raised £600K in funding. Backers included the Midlands Engine Investment Fund, Mercia Ventures and Pioneer Group... |
26.10.2023 | UK’s biotech firm ImmuOne bags €2.2M to scale up 3D human lung model for drug testing | Read this article in: UK-based ImmuOne, a biotech company that has developed a 3D human lung model to replace animal testing, announced that it has raised €2.2M in funding from MEIF Proof of Concept & Early Stage Fund, EIS funds, and Pi... |
25.10.2023 | ImmunONE Raises £2M in Funding | ImmunONE, a Hatfield, UK-based developer of a 3D human lung model to replace animal testing, raised £2M in funding. The round was led by MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia Ventures and part of the Midla... |
- | ImmuONE | “ImmuONE™ – Inhalation And Immune In Vitro Assay Solutions” |